Signet Financial Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Signet Financial Management, LLC
- $765 Million
- Q4 2024
A detailed history of Signet Financial Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Signet Financial Management, LLC holds 3,920 shares of REGN stock, worth $2.65 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
3,920
Previous 4,030
2.73%
Holding current value
$2.65 Million
Previous $4.24 Million
34.09%
% of portfolio
0.36%
Previous 0.54%
Shares
26 transactions
Others Institutions Holding REGN
# of Institutions
1,492Shares Held
85.8MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.27 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.71 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.77 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.26 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.2 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $72.4B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...